| Hib vaccine | PCV | Varicella vaccine | Rotavirus vaccine |
---|---|---|---|---|
 | (n = 282) | (n = 260) | (n = 97) | (n = 280) |
 | n (%) | n (%) | n (%) | n (%) |
Used to recommend but not accepted | 99 (35.1) | 103 (39.6) | 34 (35.1) | 98 (35.0) |
No official requirement of recommendation | 62 (22.0) | 54 (20.8) | 17 (17.6) | 56 (20.0) |
Vaccine shortage in local areas | 47 (16.7) | 38 (14.6) | 8 (8.3) | 47 (16.8) |
No additional income from increased vaccination workload | 35 (12.4) | 28 (10.8) | 10 (10.3) | 30 (10.7) |
Concern about vaccine safety | 25 (8.9) | 29 (11.2) | 8 (8.3) | 22 (7.9) |
No need for them to get vaccinated | 18 (6.4) | 11 (4.2) | 3 (3.1) | 13 (4.6) |
Concern about vaccine efficacy | 12 (4.3) | 8 (3.1) | 5 (5.2) | 12 (4.3) |